alpha-Nicotinamide adenine dinucleotide, from Saccharomyces cerevisiae, <1% beta-isomer, >=95%

Code: N6754-100MG D2-231

Application

α-Nicotinamide adenine dinucleotide has been used in superoxide dismutase activity of seminal plasma samples and in glutathione peroxidase assay of liver, kidney,...


read more

Your Price
£662.00 100MG
£794.40 inc. VAT

Application

α-Nicotinamide adenine dinucleotide has been used in superoxide dismutase activity of seminal plasma samples and in glutathione peroxidase assay of liver, kidney, testes and brain samples.

α-Nicotinamide adenine dinucleotide (αNAD) may be used together with other NAD analogues to study the specificity and kinetics of NAD-dependent and NAD-transporting enzymes and proteins, such as NAD-glycohydrolase(s) and the mitochondrial NAD+ transporter in Saccharomyces cerevisiae.

Biochem/physiol Actions

α-Nicotinamide adenine dinucleotide (α-NAD) is a substrate for renalase. α-NAD, an analog of β-NAD, when used modulates kinetics of NAD dependent enzymes.

Caution

This is not the common NAD required in the usual enzyme systems.

General description

Nicotinamide adenine dinucleotide (NAD) is an important cofactor for oxidation-reduction reactions in mitochondria.

Other Notes

α analog of β-NAD

Packaging

10, 25, 100, 250 mg in poly bottle

assay≥95%
biological sourceSaccharomyces cerevisiae
formpowder
impurities≤1% β-isomer
InChI keyBAWFJGJZGIEFAR-OPDHFMQKSA-N
InChI1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20+,21-/m1/s1
Quality Level200
SMILES stringNC(=O)c1ccc[n+](c1)[C@H]2O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
N6754-250MG
Unit:250MG
List Price: £1,380.00
Source:List Price
ADD
Cas Number7298-93-3
This product has met the following criteria: